Abstract
Purpose
Surgical site infection (SSI) is a frequent complication of elective surgery for colorectal cancer. The classical clinical markers of infection—elevations in white blood cell count, C-reactive protein (CRP) level, and body temperature—do not precisely predict SSI after elective colorectal resection. The objective of this study was to evaluate the efficacy of procalcitonin (PCT) as a tool for diagnosis of SSI in elective surgery for colorectal cancer.
Methods
A total of 114 consecutive patients undergoing elective colorectal resection for cancer were evaluated. Routine blood samples, for determining PCT level, CRP plasma concentration, and white blood cell count, were obtained on postoperative days (POD) 1 and 3. Predictive values for each of the laboratory markers were examined.
Results
SSI was diagnosed in 18 (15.7 %) of 114 patients. Patients with SSI exhibited significantly higher PCT levels (on PODs 1 and 3) and CRP levels (on POD 3) than did patients without SSI. According to receiver operating characteristic analysis, PCT showed the highest area under the curve (AUC) for predicting SSI on both PODs 1 and 3 (AUC, 0.76 and 0.77, respectively). Multivariate logistic regression analysis showed that PCT (on PODs 1 and 3) was an independent predictor for SSI (odds ratio = 14.41 and 9.79, respectively).
Conclusion
Serum PCT is more reliable laboratory marker for the early diagnosis of SSI after elective colorectal cancer surgery, compared with conventional inflammatory indicators. PCT could serve as an additional diagnostic tool for the early identification of SSI to improve clinical decision making.
Similar content being viewed by others
References
Konishi T, Watanabe T, Kishimoto J, Nagawa H (2006) Elective colon and rectal surgery differ in risk factors for wound infection: results of prospective surveillance. Ann Surg 244(5):758–763. doi:10.1097/01.sla.0000219017.78611.49
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515–518
Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8(4):R234–R242. doi:10.1186/cc2877
Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24(2):185–188
Rau BM, Kemppainen EA, Gumbs AA, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG (2007) Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 245(5):745–754. doi:10.1097/01.sla.0000252443.22360.46
Ayten R, Dogru O, Camci C, Aygen E, Cetinkaya Z, Akbulut H (2005) Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J Surg 29(2):187–189. doi:10.1007/s00268-004-7488-z
Markogiannakis H, Memos N, Messaris E, Dardamanis D, Larentzakis A, Papanikolaou D, Zografos GC, Manouras A (2011) Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction. Surgery 149(3):394–403. doi:10.1016/j.surg.2010.08.007
Papaziogas B, Anthimidis G, Koutelidakis I, Atmatzidis S, Atmatzidis K (2008) Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J Surg 32(7):1566–1567, author reply 1568
Chung YG, Won YS, Kwon YJ, Shin HC, Choi CS, Yeom JS (2011) Comparison of serum CRP and procalcitonin in patients after spine surgery. J Korean Neurosurg Soc 49(1):43–48. doi:10.3340/jkns.2011.49.1.43
Hunziker S, Hugle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B, Dick W, Eriksson U, Trampuz A (2010) The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 92(1):138–148. doi:10.2106/JBJS.H.01600
Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA, Hoksch B (2008) Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 33(5):777–780. doi:10.1016/j.ejcts.2008.02.013
Nie H, Jiang D, Ou Y, Quan Z, Hao J, Bai C, Huang X, An H (2011) Procalcitonin as an early predictor of postoperative infectious complications in patients with acute traumatic spinal cord injury. Spinal Cord 49(6):715–720. doi:10.1038/sc.2010.190
Perrakis A, Yedibela S, Schellerer V, Hohenberger W, Muller V (2010) Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc 42(10):4187–4190. doi:10.1016/j.transproceed.2010.08.070
Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15(3):260–265
Novotny A, Emmanuel K, Matevossian E, Kriner M, Ulm K, Bartels H, Holzmann B, Weighardt H, Siewert JR (2007) Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 194(1):35–39. doi:10.1016/j.amjsurg.2006.10.026
Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ (2000) Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28(9):3171–3176
Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M (2012) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 9, CD007498. doi:10.1002/14651858.CD007498.pub2
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. doi:10.1016/S1473-3099(12)70323-7
Dorge H, Schondube FA, Dorge P, Seipelt R, Voss M, Messmer BJ (2003) Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 51(6):322–326. doi:10.1055/s-2003-45425
Uchino M, Ikeuchi H, Tsuchida T, Nakajima K, Tomita N, Takesue Y (2009) Surgical site infection following surgery for inflammatory bowel disease in patients with clean-contaminated wounds. World J Surg 33(5):1042–1048. doi:10.1007/s00268-009-9934-4
Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18(2):79–87
Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK (2007) Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142(2):134–142. doi:10.1001/archsurg.142.2.134
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takakura, Y., Hinoi, T., Egi, H. et al. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbecks Arch Surg 398, 833–839 (2013). https://doi.org/10.1007/s00423-013-1095-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-013-1095-0